Drug Discovery

This 6 episode miniseries will take listeners behind the scenes of a range of projects at the Drugs for Neglected Diseases initiative

How bioelectronic assays helped demonstrate the value of 3D iPSC cultures in modeling human brain development.

Are all antibiotics doomed to eventual impotence? New work from Oxford could change the game by defeating resistance itself.

Thorben Seeger wants to democratize the data held by the world’s leading genomic institutions. But what exactly does he mean by “democratize”?

Our eBook features drug development stories, a drive for novel excipients, new technologies, and more.

Boston bioscientists have found an unlikely ally in anthrax toxins, which could form the basis for a new kind of painkiller.

Enveda Biosciences Founder Viswa Colluru shares the lessons he has learned whilst charting the vast terra incognita of nature’s chemical structure

Work by an international team in Japan has found a new and effective way to attack cancer inside the body.

Find out how nanotechnology can overcome challenges in drug delivery to the eye.

We talk to Roche’s Paulo Fontoura about Evrysdi and its impact on patient lives.